Market Overview:
The global levocetirizine dihydrochloride API market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of allergic rhinitis and asthma, rising demand for levocetirizine dihydrochloride tablets and oral solutions, and growing investments by pharmaceutical companies in R&D activities. However, the high cost of advanced therapies may restrain the growth of this market to some extent. Based on type, the global levocetirizine dihydrochloride API market can be segmented into purity ≥98%.
Product Definition:
Levocetirizine Dihydrochloride API is an antihistamine drug which is used in the treatment of allergies and hives. It works by blocking the action of histamine, a chemical that is released during an allergic reaction. This helps to relieve symptoms such as itching, swelling, and sneezing.
Purity≥98%:
Purity 98% is a trade name for a series of highly pure, crystalline dihydrochloride, manufactured by GFS Chemicals. It's an odorless and colorless liquid that has no taste or flavor. Purity 98% is used as the raw material in the manufacturing of various pharmaceuticals including generic drugs such as Valerian (Ketoprofen) and Melatonin (N-3).
Purity
Purity levels of 98% or more are considered as pure by nature. Such products have very less or no impurities in them. They are manufactured using various processes like distillation, filtration, and crystallization to extract the final product from raw materials like chemicals and other ingredients.
Application Insights:
Levocetirizine dihydrochloride tablets were the largest revenue-generating segment in 2017. The product is used as an anti-allergy and anti-asthma medication. It reduces the frequency of allergic reactions and asthma attacks, thereby, reducing medication needs. As a result, it helps patients lead a normal life without suffering from allergies or asthma symptoms.
The oral solution segment is expected to witness significant growth over the forecast period owing to its wide application in various industries including pharmaceuticals and food & beverage sector among others.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing product demand, rising incidence of allergies and asthma, and growing awareness about drug safety & efficacy among patients. In addition, presence of key players with extensive R&D capabilities in this region will help boost market growth over the forecast period.
Asia Pacific is anticipated to witness fastest growth during the forecast period owing to factors such as improving healthcare infrastructure & reimbursement policies; rising prevalence of allergic disorders; increase in consumer disposable income levels; and rise in medical tourism activities due to availability of effective treatment at affordable costs coupled with high quality standards prevailing in Asian countries as compared to developed nations across globe.
Growth Factors:
- Increasing prevalence of allergic rhinitis and asthma
- Growing demand for levocetirizine in pediatric population
- Rising awareness about the benefits of levocetirizine among physicians and patients
- Technological advancements in the field of levocetirizine research and development
- Expansion of distribution channels
Scope Of The Report
Report Attributes
Report Details
Report Title
Levocetirizine Dihydrochloride API Market Research Report
By Type
Purity≥98%, Purity<98%
By Application
Levocetirizine Dihydrochloride Tablets, Levocetirizine Dihydrochloride Oral Solution, Others
By Companies
Dr. Reddy’s Laboratories Ltd., Metrochem API Private Limited, Om Pharmaceutical Industries, Symed Labs Limited, Glenmark Pharmaceuticals, Granules India Limited, Chongqing Huapont Pharmaceutical, Glochem Industries, Cipla, Nishchem International Pvt. Ltd, Maps Laboratories Private Limited, Supriya Lifescience Limited
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
207
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Levocetirizine Dihydrochloride API Market Report Segments:
The global Levocetirizine Dihydrochloride API market is segmented on the basis of:
Types
Purity≥98%, Purity<98%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Levocetirizine Dihydrochloride Tablets, Levocetirizine Dihydrochloride Oral Solution, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Dr. Reddy’s Laboratories Ltd.
- Metrochem API Private Limited
- Om Pharmaceutical Industries
- Symed Labs Limited
- Glenmark Pharmaceuticals
- Granules India Limited
- Chongqing Huapont Pharmaceutical
- Glochem Industries
- Cipla
- Nishchem International Pvt. Ltd
- Maps Laboratories Private Limited
- Supriya Lifescience Limited
Highlights of The Levocetirizine Dihydrochloride API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity≥98%
- Purity<98%
- By Application:
- Levocetirizine Dihydrochloride Tablets
- Levocetirizine Dihydrochloride Oral Solution
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Levocetirizine Dihydrochloride API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Levocetirizine Dihydrochloride API is a prescription medication used to treat the symptoms of seasonal allergies, such as sneezing, runny nose, and itchy eyes. Levocetirizine Dihydrochloride API is also used to prevent these symptoms from occurring in people who are allergic to pollen.
Some of the major players in the levocetirizine dihydrochloride api market are Dr. Reddy’s Laboratories Ltd., Metrochem API Private Limited, Om Pharmaceutical Industries, Symed Labs Limited, Glenmark Pharmaceuticals, Granules India Limited, Chongqing Huapont Pharmaceutical, Glochem Industries, Cipla, Nishchem International Pvt. Ltd, Maps Laboratories Private Limited, Supriya Lifescience Limited.
The levocetirizine dihydrochloride api market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Levocetirizine Dihydrochloride API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Levocetirizine Dihydrochloride API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Levocetirizine Dihydrochloride API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Levocetirizine Dihydrochloride API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Levocetirizine Dihydrochloride API Market Size & Forecast, 2020-2028
4.5.1 Levocetirizine Dihydrochloride API Market Size and Y-o-Y Growth
4.5.2 Levocetirizine Dihydrochloride API Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Purity≥98%
5.2.2 Purity<98%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Levocetirizine Dihydrochloride Tablets
6.2.2 Levocetirizine Dihydrochloride Oral Solution
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Levocetirizine Dihydrochloride API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Levocetirizine Dihydrochloride API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Purity≥98%
9.6.2 Purity<98%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Levocetirizine Dihydrochloride Tablets
9.10.2 Levocetirizine Dihydrochloride Oral Solution
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Purity≥98%
10.6.2 Purity<98%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Levocetirizine Dihydrochloride Tablets
10.10.2 Levocetirizine Dihydrochloride Oral Solution
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Purity≥98%
11.6.2 Purity<98%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Levocetirizine Dihydrochloride Tablets
11.10.2 Levocetirizine Dihydrochloride Oral Solution
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Purity≥98%
12.6.2 Purity<98%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Levocetirizine Dihydrochloride Tablets
12.10.2 Levocetirizine Dihydrochloride Oral Solution
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Purity≥98%
13.6.2 Purity<98%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Levocetirizine Dihydrochloride Tablets
13.10.2 Levocetirizine Dihydrochloride Oral Solution
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Levocetirizine Dihydrochloride API Market: Competitive Dashboard
14.2 Global Levocetirizine Dihydrochloride API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Dr. Reddy’s Laboratories Ltd.
14.3.2 Metrochem API Private Limited
14.3.3 Om Pharmaceutical Industries
14.3.4 Symed Labs Limited
14.3.5 Glenmark Pharmaceuticals
14.3.6 Granules India Limited
14.3.7 Chongqing Huapont Pharmaceutical
14.3.8 Glochem Industries
14.3.9 Cipla
14.3.10 Nishchem International Pvt. Ltd
14.3.11 Maps Laboratories Private Limited
14.3.12 Supriya Lifescience Limited
